Evidence map›Paper›PMID 41444942›Full record

Observational studyBMC infectious diseases2025

The use of recommended vaccinations among patients with chronic diseases in relation to attitudes toward vaccination and anxiety levels.

Anna Lewandowska, Tomasz Lewandowski, Grzegorz Rudzki, Michał Próchnicki, Anna Bartosiewicz, Aleksandra Stryjkowska-Góra, Tomasz Góra, Barbara Zych, Barbara Laskowska, Agnieszka Bielec and 1 more

Abstract readObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anna LewandowskaFaculty of Healthcare, State Academy of Applied Sciences in Jaroslaw, Czarnieckiego Street 16, Jaroslaw, 37-500, Poland. am.lewandowska@poczta.fm.
Tomasz LewandowskiFaculty of Technical Engineering, State Academy of Applied Sciences in Jaroslaw, Jaroslaw, Poland.
Grzegorz RudzkiChair and Department of Endocrinology, Medical University of Lublin, Lublin, Poland.
Michał PróchnickiDepartment of Psychiatry, Psychotherapy and Early Intervention, Medical University of Lublin, Lublin, Poland.
Anna BartosiewiczFaculty of Health Sciences and Psychology, Collegium Medicum of Rzeszów University, Rzeszów, Poland.
Aleksandra Stryjkowska-GóraDepartment of Oncology, Radiotherapy and Translational Medicine, University of Rzeszow, Rzeszow, Poland.
Tomasz GóraClinical Department of Gynecology and Obstetrics, Independent Public Health Care Complex in Rzeszow, Rzeszow, Poland.
Barbara ZychFaculty of Health Sciences and Psychology, Collegium Medicum of Rzeszów University, Rzeszów, Poland.
Barbara LaskowskaFaculty of Healthcare, State Academy of Applied Sciences in Jaroslaw, Czarnieckiego Street 16, Jaroslaw, 37-500, Poland.
Agnieszka BielecCollegium Masoviense, University of Health Sciences in Zyrardow, Zyrardow, Poland.
Beata BidaCollegium Masoviense, University of Health Sciences in Zyrardow, Zyrardow, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccording to the guidelines of the European Centre for Disease Control and Prevention, a specialized vaccination protocol is recommended for individuals with chronic conditions such as asplenia, diabetes, cardiovascular diseases, HIV infection, liver diseases, pulmonary diseases, kidney diseases, and immunodeficiency. The recommended vaccinations for chronically ill patients include the seasonal influenza vaccine, periodic booster doses of tetanus, diphtheria, and pertussis vaccines, the herpes zoster vaccine, and the pneumococcal vaccine. Since December 2020, the COVID-19 vaccine has also been recommended for this group. The aim of the study was to assess the use of recommended vaccinations in patients with chronic diseases, to analyze factors influencing patients' attitudes towards vaccinations, as well as the severity of fear of getting sick and the correlation of fear with attitudes towards vaccinations.

methodsA cross-sectional study with comparison groups was conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. A convenience sampling method was applied, and the study was carried out among oncology patients, patients with chronic obstructive pulmonary disease (COPD), and healthy individuals in the control group. The study utilized a survey questionnaire, the Positive Health Behavior Scale, and the SL-C Trait Anxiety Scale.

resultsThe study group included patients with cancer, patients with obstructive pulmonary disease, and healthy controls. The most frequently received vaccination was against COVID-19, both in the group of oncology patients (74%), in the group of patients with obstructive pulmonary disease (65%) and in the control group (85%). The percentage of influenza vaccinations was higher in patients with COPD (OR: 1.6, p < 0.05) compared to patients with cancer or the control group. Furthermore, a significant increase in recommended vaccinations was observed in age groups ≥ 65 years (OR: 1.9, p < 0.01) compared to younger age groups in both groups I and II. Fear of severe illness (47%) was the main reason for vaccination. Participants learned about vaccines primarily from the internet (35%). The occurrence of side effects after vaccination did not significantly influence the decision to revaccinate (chi-square = 0.24, p = 0.622).

conclusionsPatients are most willing to be vaccinated against COVID-19, while the percentage of vaccinations with other recommended vaccines in clinical risk groups is below the desired level. Due to the high percentage of people vaccinated against COVID-19 and the mild course of the disease in most cases, it can be concluded that vaccination provided high protection against severe disease and hospitalization among vulnerable groups of the population. CLINICAL TRIAL: Not applicable.

Indexed as

AnxietyVaccinationAdultAgedChronic DiseaseCOVID-19COVID-19 VaccinesCross-Sectional StudiesFemaleHumansMaleMiddle AgedNeoplasmsPulmonary Disease, Chronic ObstructiveSARS-CoV-2Surveys and QuestionnairesCOVID-19 VaccinesAnxietyCancerChronic obstructive pulmonary diseasePatient attitudesRecommended vaccinations

Identifiers

PMID41444942
PMCPMC12729346

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.